Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
Top Cited Papers
- 31 October 2010
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 11 (10), 927-933
- https://doi.org/10.1016/s1470-2045(10)70207-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissectionJournal of Surgical Oncology, 2010
- Sentinel Lymph Node Biopsy in Breast CancerAnnals of Surgery, 2010
- Surgeon Training, Protocol Compliance, and Technical Outcomes From Breast Cancer Sentinel Lymph Node Randomized TrialJNCI Journal of the National Cancer Institute, 2009
- Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literatureEuropean Journal of Surgical Oncology, 2008
- Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trialThe Lancet Oncology, 2007
- Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled studyThe Lancet Oncology, 2006
- Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJNCI Journal of the National Cancer Institute, 2006
- A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast CancerThe New England Journal of Medicine, 2003
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958